Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.

Experimental gerontology - 1 Oct 2004

Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri V A M, Bavazzano A, Comolli R, Paoletti F, La Porta C A M

Abstract excerpt

Alzheimer's disease (AD) is a progressive neurodegenerative illness and the most frequent cause of dementia in the elderly. The identification of activated microglia within neuritic plaques, coupled with the presence of numerous inflammatory proteins, suggests that inflammation is an integral par...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD40 Antigens

Share to Diagnosis, Differential

Share to Parkinson Disease

Share to Transforming Growth Factor beta

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 15501026
DOI: 10.1016/j.exger.2004.07.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15501026-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.PMID 15501026Read ↗

Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease.Semantic proximity Read ↗

+10 T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution.Semantic proximity Read ↗

Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review.Semantic proximity Read ↗

Inflammatory and Pro-resolving Mediators in Frontotemporal Dementia and Alzheimer's Disease.Semantic proximity Read ↗

Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.Semantic proximity Read ↗

Decreased interleukin-8 levels in the peripheral blood of Alzheimer’s patientsSemantic proximity Read ↗

Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotectionSemantic proximity Read ↗

The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease.Semantic proximity Read ↗

Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.Semantic proximity Read ↗

Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s DiseaseSemantic proximity Read ↗

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PDSemantic proximity Read ↗

Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.